An endogenous peptide that causes vasodilation and is inactivated by angiotensin converting enzyme is:
**Core Concept:** The correct answer is related to the understanding of endogenous peptides and their physiological actions, particularly those that affect vasodilation and are regulated by enzymes like angiotensin converting enzyme (ACE). ACE is an enzyme that plays a crucial role in the renin-angiotensin-aldosterone system (RAAS), which is involved in blood pressure regulation.
**Why the Correct Answer is Right:** ACE is an enzyme that plays a significant role in the RAAS system, which is responsible for regulating blood pressure and fluid balance in the body. ACE inactivates angiotensin I and II, which are potent vasoconstrictors (increase blood vessel contraction). In contrast, the correct answer is an endogenous peptide that causes vasodilation (widening of blood vessels) and is regulated by ACE.
**Why Each Wrong Option is Incorrect:**
A. Angiotensin II: This is a vasoconstrictor (increases blood vessel contraction) and is not the correct answer as it is not regulated by ACE.
B. Bradykinin: Bradykinin is a vasodilator (increases blood vessel diameter) but is also regulated by ACE, making it incorrect as an answer.
C. Thromboxane A2: This is a vasoconstrictor (increases blood vessel contraction) and is not regulated by ACE, making it the wrong choice.
D. Endothelin-1: Endothelin-1 is a vasoconstrictor (increases blood vessel contraction) and is regulated by ACE, rendering it an incorrect answer.
**Clinical Pearl:** Understanding the role of ACE in the RAAS system is crucial for understanding hypertension (high blood pressure) and its treatment strategies. ACE inhibitors, which are medications used to treat hypertension, work by blocking ACE and preventing the inactivation of vasodilatory peptides like bradykinin and substance P. This leads to vasodilation and reduced blood pressure.
**Correct Answer:** Angiotensin I: This is an angiotensin peptide that causes vasodilation (widening of blood vessels) and is inactivated by ACE. Angiotensin I is the precursor to angiotensin II, which is a potent vasoconstrictor (increases blood vessel contraction). By inhibiting the conversion of angiotensin I to angiotensin II, ACE inhibitors achieve their therapeutic effect of reducing blood pressure.